期刊文献+

多发性内分泌腺瘤病1型患者血液细胞来源特异性诱导多能干细胞的建立

Generation of multiple endocrine neoplasia 1 patient-specific induced pluripotent stem cells from blood cell
下载PDF
导出
摘要 目的:建立多发性内分泌腺瘤病1型(multiple endocrine neoplasia 1,MEN1)患者血液细胞来源的特异性诱导多能干细胞(induced pluripotent stem cells,iPSCs)模型。方法:将表达Oct4、Sox2、Lin28、L-Myc和Klf4转录因子的oriP/EBNA1附着体电转染MEN1患者血液细胞使其重编程获得iPSCs,并通过碱性磷酸酶染色、核型鉴定、基因测序、RT-PCR反应、畸胎瘤形成实验及类胚体形成实验检测其特性。结果:获得的i PSCs碱性磷酸酶染色呈阳性,核型正常,测序结果显示在其第9号外显子存在c.1288 G>T位点突变,表达干细胞多能性基因Sox2、Oct4、Nanog和Klf4和Lin28,体内畸胎瘤形成实验可分化为内、中、外三胚层细胞,体外可形成类胚体。结论:成功获得携带第9号外显子c.1288 G>T位点突变的MEN1患者血液细胞来源的特异性iPSCs,为后续机制研究奠定基础。 Objective:To establish patient - specific induced pluripotent stem cells ( iPSCs ) model of multiple en-docrine neoplasia 1(MEN1) patients blood cells. Methods: Blood cells from MEN1 patient were infected by episomal vectors with an oriP/EBNA - 1 ( Epstein - Barr nuclear antigen - 1) backbone for delivering the reprogramming genes Oct4, Sox2, Lin28 ,L - Myc,and Klf4 to generate iPSCs. The charateristic of the obtained iPSCs were verified by alka-line phosphatase staining,karyotyping analysis,gene sequencing,RT - PCR,teratoma test,and the formation of embry- oid body. Results : Alkaline phosphatase staining were positive. The obtained iPSCs carried normal karyotype and ex-pressed the pluripotent genes Sox2, Oct4, Nanog, Klf4 and Lin28. Sequencing analysis showed that it had a heterozy-gous G 〉 T mutation on the exon 9 of Menl gene. In the teratoma test, three germ layer cells were found. EBs were formed by suspended culture. Conclusion:The iPSCs from MEN1 patien ts blood cells with multipotency could be suc-cessfully generated, which lay the foundation of further mechanism study.
出处 《现代肿瘤医学》 CAS 2017年第14期2219-2222,共4页 Journal of Modern Oncology
基金 广东省广州市海珠区科技计划项目(编号:2014-cg-05)
关键词 多发性内分泌腺瘤病1型 血液细胞 转录因子 重编程 诱导多能干细胞 multiple endocrine neoplasia 1,blood cells ,reprogramming vector, reprogramming, induced pluripotent stem cells
  • 相关文献

参考文献6

二级参考文献104

  • 1周玉球,肖奇志,黄丽娟,肖鸽飞,李文典,朱兰芳,陈紫霞,张玉梅.HbH病患儿临床表现与基因型相关性的研究[J].中华儿科杂志,2004,42(9):693-696. 被引量:25
  • 2Yamanaka S. Patient-specific pluripotent stem cells become even more accessible. Cell Stem Cell 2010; 7:1-2.
  • 3Ye Z, Zhan H, Mali P, et al. Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders. Blood 2009; 114:5473-5480.
  • 4Loh YH, Agarwal S, Park IH, et al. Generation of induced pluripotent stem cells from human blood. Blood 2009; 113:5476-5479.
  • 5Giorgetti A, Montserrat N, Aasen T, et al. Generation of induced pluripotent stem cells from human cord blood using OCT4 and SOX2. Ceil Stem Cell 2009; 5:353-357.
  • 6Kunisato A, Wakatsuki M, Shinba H, et al. Direct Generation of Induced Pluripotent Stem Cells from Human Non-mobilized Blood. Stem Cells Dev 2010 Sep 14. doi:10.1089/ scd.2010.0063.
  • 7Brown ME, Rondon E, Rajesh D, et al. Derivation of induced pluripotent stem cells from human peripheral blood T lym-phocytes. PLoS One 2010; 5:el 1373.
  • 8Seki T, Yuasa S, Oda M, et al. Generation of induced pluripotent stem cells from human terminally differentiated circulating T cells. Cell Stem Cell 2010; 7:11-14.
  • 9Loh YH, Hartung O, Li H, et al. Reprogramming of T cells from human peripheral blood. Cell Stern Cell 2010; 7:15 - 19.
  • 10Staerk J, Dawlaty MM, Gao Q, et al. Reprogramming of hu-man peripheral blood cells to induced pluripotent stem cells. Cell Stem Cell 2010; 7:20-24.

共引文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部